Related articles

• Review

  Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.

  Vox Sang. 2004 Jul 1;87(1):34-40.

• Article

  A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation.

  Br. J. Haematol. 2003 Mar 1; 120 (5): 808-13.

• Case Reports

  [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].

  Ann. Biol. Clin. (Paris). 2011 Nov 1;69(6):713-9.

Show more related articles...